Table 3:
Adjusted hazard of developing selected outcomes during follow-up among C282Y homozygotes, compared with wild-type patients
| Adjusted* hazard ratio (95% CI) | ||||
|---|---|---|---|---|
| HR | Lower CL | Upper CL | p-value | |
| All-cause death | 1.436 | 1.182 | 1.745 | 0.0003 |
| Liver cancer | 8.297 | 3.97 | 17.341 | <0.001 |
| Knee or hip joint replacement | 3.063 | 2.461 | 3.811 | <0.001 |
| Diabetes | 0.844 | 0.667 | 1.067 | 0.1567 |
| Cirrhosis | 3.872 | 3.047 | 4.920 | <0.001 |
| Osteoarthritis | 1.719 | 1.472 | 2.007 | <0.001 |
* Adjusted for age and sex